SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-222916
Filing Date
2020-08-18
Accepted
2020-08-18 08:11:32
Documents
14
Period of Report
2020-08-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d87267d8k.htm   iXBRL 8-K 29482
2 EX-99.1 d87267dex991.htm EX-99.1 7872
6 GRAPHIC g87267g0818033943166.jpg GRAPHIC 4650
  Complete submission text file 0001193125-20-222916.txt   168132

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgen-20200814.xsd EX-101.SCH 3090
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20200814_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20200814_pre.xml EX-101.PRE 10966
7 EXTRACTED XBRL INSTANCE DOCUMENT d87267d8k_htm.xml XML 3269
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 201111778
SIC: 2836 Biological Products, (No Diagnostic Substances)